Drug Type Synthetic peptide |
Synonyms CS 14, CS14**** |
Target |
Action modulators |
Mechanism GCGR modulators(Glucagon receptor modulators), GIPR modulators(Gastric inhibitory polypeptide receptor modulators), GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | China | 01 Jan 2025 | |
| Obesity | Preclinical | China | 01 Jan 2025 |






